Zobrazeno 1 - 10
of 4 029
pro vyhledávání: '"Tezuka, H."'
Autor:
Tezuka H; Department of Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University (FHU), Aichi, Japan., Imai S; Department of Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University (FHU), Aichi, Japan.; School of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo, Japan.; Institute of Metabolic Function, Kanagawa, Japan.
Publikováno v:
Frontiers in nutrition [Front Nutr] 2024 May 24; Vol. 11, pp. 1399687. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).
Autor:
Stegner, A. R., Tezuka, H., Andlauer, T., Stutzmann, M., Thewalt, M. L. W., Brandt, M. S., Itoh, K. M.
The fourfold degeneracy of the boron acceptor ground state in silicon, which is easily lifted by any symmetry breaking perturbation, allows for a strong inhomogeneous broadening of the boron-related electron paramagnetic resonance (EPR) lines, e.g. b
Externí odkaz:
http://arxiv.org/abs/1004.0786
Autor:
Tezuka, H., Stegner, A. R., Tyryshkin, A. M., Shankar, S., Thewalt, M. L. W., Lyon, S. A., Itoh, K. M., Brandt, M. S.
The electron paramagnetic resonance (EPR) linewidths of B acceptors in Si are found to reduce dramatically in isotopically purified 28Si single crystals. Moreover, extremely narrow substructures in the EPR spectra are visible corresponding to either
Externí odkaz:
http://arxiv.org/abs/1003.4339
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kubota H; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan., Kunisawa K; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan., Wulaer B; Laboratory of Health and Medical Science Innovation (HMSI), Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan., Hasegawa M; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan., Kurahashi H; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan., Sakata T; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan., Tezuka H; Department of Cellular Function Analysis, Research Promotion and Support Headquarters, Fujita Health University, Toyoake, Aichi, Japan., Kugita M; Education and Research Facility of Animal Models for Human Diseases, Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan., Nagao S; Education and Research Facility of Animal Models for Human Diseases, Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan., Nagai T; Division of Behavioral Neuropharmacology International Center for Brain Science (ICBS), Fujita Health University, Toyoake, Aichi, Japan., Furuyashiki T; Division of Pharmacology, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan., Narumiya S; Department of Drug Discovery Medicine, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, Japan., Saito K; Laboratory of Health and Medical Science Innovation (HMSI), Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan.; Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan.; Japanese Drug Organization of Appropriate Use and Research, Nagoya, Aichi, Japan., Nabeshima T; Laboratory of Health and Medical Science Innovation (HMSI), Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan.; Japanese Drug Organization of Appropriate Use and Research, Nagoya, Aichi, Japan., Mouri A; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan.; Japanese Drug Organization of Appropriate Use and Research, Nagoya, Aichi, Japan.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2023 Sep; Vol. 180 (18), pp. 2393-2411. Date of Electronic Publication: 2023 May 17.
Autor:
Morita N; Department of Disease Control and Prevention, Fujita Health University, Toyoake, Aichi, Japan., Hoshi M; Department of Disease Control and Prevention, Fujita Health University, Toyoake, Aichi, Japan.; Department of Informative Clinical Medicine, Fujita Health University, Toyoake, Aichi, Japan., Tezuka H; Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi, Japan., Ando T; Joint Research Laboratory of Clinical Medicine, Fujita Health University, Toyoake, Aichi, Japan., Yoshida S; Department of Informative Clinical Medicine, Fujita Health University, Toyoake, Aichi, Japan., Sato F; Department of Informative Clinical Medicine, Fujita Health University, Toyoake, Aichi, Japan., Yokoi H; Department of Informative Clinical Medicine, Fujita Health University, Toyoake, Aichi, Japan., Ito H; Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi, Japan., Saito K; Department of Disease Control and Prevention, Fujita Health University, Toyoake, Aichi, Japan.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2023 May 01; Vol. 7 (5), pp. 353-363.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tanaka K; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Kondo T; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Narita M; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Muta T; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Yoshida S; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Sato D; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan., Suda Y; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Hamada Y; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Tezuka H; Department of Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan., Kuzumaki N; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Electronic address: n-kuzumaki@hoshi.ac.jp., Narita M; Department of Pharmacology, Hoshi University, School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Electronic address: narita@hoshi.ac.jp.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2023 Mar 12; Vol. 648, pp. 36-43. Date of Electronic Publication: 2023 Jan 24.